Awards/COOPERATIVE AGREEMENT (B)

$57,141,857

Department of Health and Human Services·National Institutes of Health

ACTION DATE2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_UM1AI069412_075

Award description

HARVARD MEDICAL SCHOOL VACCINE CLINICAL TRIALS UNIT

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds Harvard Medical School's vaccine clinical trials unit to conduct research and testing of vaccine candidates.

Sub-sectors

vaccine-developmentclinical-trialsnih-research

Why this matters

Strengthens U.S. vaccine development infrastructure and clinical trial capacity for pandemic preparedness and emerging infectious diseases.

Supply-chain signal

Signals sustained demand for clinical trial services, regulatory expertise, and vaccine manufacturing partnerships.

U.S.–China competition angle

Reflects U.S. investment in domestic vaccine R&D capabilities to reduce dependence on foreign vaccine supply chains.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002094.

Period of performance

Start

2007-01-15

End

2027-11-30

Status

activein 562 days

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_UM1AI069412_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.